Psyence Biomedical LTD. 6-K Filing
Ticker: PBMWW · Form: 6-K · Filed: Nov 21, 2025 · CIK: 1985062
Sentiment: neutral
Filing Stats: 158 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2025-11-21 17:18:10
Filing Documents
- ea0266630-6k_psyence.htm (6-K) — 9KB
- ea026663001ex99-1_psyence.htm (EX-99.1) — 20KB
- 0001213900-25-113704.txt ( ) — 30KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-41937 Psyence Biomedical Ltd. (Translation of registrant’s name into English) 121 Richmond Street West Penthouse Suite 1300 Toronto, Ontario M5H 2K1 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Press Release, dated November 12, 2025 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: November 21, 2025 Psyence Biomedical Ltd. By: /s/ Warwick Corden-Lloyd Name: Warwick Corden-Lloyd Title: Chief Financial Officer 2